Immediate Impact
4 by Nobel laureates 57 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Paramita Sen being referenced
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma
2014
Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Paramita Sen | 96 | 74 | 76 | 184 | 121 | 22 | 338 | |
| Kriti Mittal | 132 | 133 | 25 | 154 | 43 | 28 | 343 | |
| Aiping Ma | 145 | 57 | 81 | 104 | 36 | 23 | 379 | |
| Yoshihiro Noji | 47 | 47 | 23 | 67 | 129 | 19 | 382 | |
| Saud Azam | 102 | 122 | 12 | 68 | 39 | 22 | 318 | |
| Naohiro Uchida | 121 | 173 | 25 | 51 | 33 | 32 | 357 | |
| Caterina Messina | 112 | 126 | 40 | 55 | 106 | 24 | 383 | |
| Takahiro Ichikawa | 70 | 55 | 15 | 136 | 136 | 29 | 368 | |
| John Bainbridge | 30 | 94 | 36 | 112 | 26 | 24 | 361 | |
| Stefano Monni | 42 | 73 | 26 | 83 | 89 | 18 | 341 | |
| Rolf Mertens | 80 | 136 | 20 | 97 | 128 | 16 | 360 |
All Works
Loading papers...